These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 5031037

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Treatment of parkinsonism with levodopa.
    Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM.
    Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Long-term effects of levodopa in the severely disabled patient.
    Sacks OW, Messeloff CR, Schwartz WF.
    JAMA; 1970 Sep 28; 213(13):2270. PubMed ID: 5468938
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. [The addition of amantadine to prolonged treatment with L-Dopa. Considerations on 20 cases].
    Giuffrè R, Gambacorta D.
    Minerva Med; 1971 Oct 31; 62(82):4009-12. PubMed ID: 5125066
    [No Abstract] [Full Text] [Related]

  • 69. Sustained levodopa therapy in parkinsonism.
    Hunter KR, Shaw KM, Laurence DR, Stern GM.
    Lancet; 1973 Oct 27; 2(7835):929-31. PubMed ID: 4126558
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
    Tissot R, Gaillard JM, Guggisberg M, Gauthier G, de Ajuriaguerra J.
    Presse Med (1893); 1969 Apr 05; 77(17):619-22. PubMed ID: 5785081
    [No Abstract] [Full Text] [Related]

  • 79. [Drug therapy of Parkinson's disease with amantadine and levodopa].
    Fieschi C, Nardini M, Casacchia M, Reitano M, Tedone ME, Ferrari P, Robotti E.
    Sist Nerv; 1970 Apr 05; 22(2):126-43. PubMed ID: 5504552
    [No Abstract] [Full Text] [Related]

  • 80. Combined L-dopa and amantadine in Parkinsonism.
    Pollock M, Jorgensen PB.
    Aust N Z J Med; 1972 Aug 05; 2(3):252-5. PubMed ID: 4564049
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.